Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ruanxin Biotechnology

Request full access

Hyaluronic acid and chondroitin sulfate production supplier.

ChinaFounded 2017Health

About Ruanxin Biotechnology

Shandong Ruanxin (Runxin) Biotechnology Co., Ltd. is a global supplier and manufacturer specializing in the production and research of sodium hyaluronate and chondroitin sulfate. The company was established in 1998 and is located in Qufu City, Shandong Province, China. Its predecessor was a casing plant in the 1950s that exported products to Western countries. The company began producing chondroitin sulfate and heparin sodium in 1998, started its own hyaluronic acid (HA) production in 2006, and in 2012, it began offering OEM processing and export services after constructing a D-level (100,000 level) GMP workshop.

Ruanxin Biotechnology's business model encompasses the research and development, production, and sales of its core products. The company serves a global market, providing raw materials and finished products to various industries. Its offerings include different grades of sodium hyaluronate powder (pharmaceutical, injection, eye drop, cosmetic, and food grade) and chondroitin sulfate. The company's products are used in medical cosmetology for skin filling and facial atrophy improvement, as well as in orthopedics for treating joint injuries and early osteoarthritis. They also manufacture products for veterinary applications, including for horses and other pets. Additionally, their materials are used in ophthalmic surgery and as anti-adhesion gels.

A significant part of Ruanxin's business is its comprehensive OEM and ODM (private label) services. This includes customized formulation development, packaging design, and quality control to meet specific client requirements for products like sodium hyaluronate injectable gels. The company provides extensive after-sales support, including detailed product instructions, technical support, and management of quality issues. Buttressed by a highly productive R&D team and a fully equipped testing center, the production base has a daily output of over 100,000 units.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
17.0/100
Industry
Health
Sector
Ophthalmology, Orthopedic, Biotech and Pharma
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Apr 2026 $14M $55M Real Power Capital · Nuoyu Capital ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Ruanxin Biotechnology in its local ecosystem

Live from Dealroom

The Ruanxin Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Real Power Capital
  • Nuoyu Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ruanxin Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ruanxin Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.